Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study.
Akgör U, Basaran D, Meydanli MM, Kuscu E, Demirkiran F, Topuz S, Sancı M, Akbayır O, Gultekin M, Salihoglu MY, Akilli H, Bese T, Fırat Z, Sozen H, Ozgul N, Ayhan A.
Akgör U, et al. Among authors: topuz s.
Int J Gynecol Cancer. 2024 Sep 2;34(9):1382-1388. doi: 10.1136/ijgc-2024-005368.
Int J Gynecol Cancer. 2024.
PMID: 38839421